2CUREX vs ALK-B: Side-by-Side Comparison
Compare 2cureX AB (2CUREX) and ALK-Abelló A/S (ALK-B) side by side: market cap SEK 46.39M vs DKK 54.11B. Financials, growth and model signals on Bullrun.
| Metric | 2CUREX | ALK-B |
|---|---|---|
| Company | 2cureX AB | ALK-Abelló A/S |
| Country / Exchange | Denmark · ST | Denmark · CO |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | SEK 46.39M | DKK 54.11B |
| P/E ratio | — | 42.0 |
| Dividend yield | — | 0.66% |
| Valuation model | — | 6.2% overvalued |
| Revenue (latest FY) | SEK 0 | DKK 6.31B |
| Revenue growth YoY | — | +14.0% |
| Net income | SEK -4.55M | DKK 1.20B |
| Gross margin | — | 67.1% |
| Diluted EPS | -0.18 | 540.00 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.